You are here

Data

For older patients, Paxlovid cuts COVID hospitalization, death risk and speeds symptom relief --two new studies

New findings from two studies have tied use of the antiviral drug nirmatrelvir-ritonavir (Paxlovid) to a reduction in COVID-19 hospitalizations and death, as well as to faster resolution of symptoms and less use of healthcare resources.

Benefit seen only in older patients

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

H5N1 bird flu might be more prevalent among humans than public health data shows

As H5N1 bird flu continues to spread around the US, health officials recently found that 7 percent of dairy workers tested on farms in two states had evidence of recent infection — and some had signs of infection even when they didn’t feel sick.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

COVID-19's impact on global flu patterns and evolution traced in new study

Seasonal influenza epidemics impose substantial burdens on health care systems and cause >5 million hospitalizations of adults each year. The current approach to influenza vaccine development requires comprehensive surveillance of circulating strains, which are constantly moving from continent to continent....

Problem, Solution, SitRep, or ?: 

COVID overview: The Year in Review

This year's headlines on COVID-19 featured new research on COVID-related mortality, post-acute sequelae of infection, vaccine safety, and potential therapeutics.

COVID Deaths Are Down, but...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Data
howdy folks
Page loaded in 0.746 seconds.